# Single Versus Double Injection Costoclavicular Block

> **NCT03595514** · NA · UNKNOWN · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 90 (estimated)

## Conditions studied

- Upper Extremity Injury

## Interventions

- **OTHER:** Single injection
- **OTHER:** Double injection
- **DRUG:** lidocaine, bupivacaine, epinephrine, dexamethasone

## Key facts

- **NCT ID:** NCT03595514
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-30
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2018-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03595514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03595514, "Single Versus Double Injection Costoclavicular Block". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03595514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
